Skip to main content
Clinical Trials/ACTRN12616000903482
ACTRN12616000903482
Not yet recruiting
Phase 3

The Obstructive Sleep apnoea Intervention in AF (OSI-AF) randomised trial: Obstructive sleep apnoea treatment to reduce atrial fibrillation burden and morbidity

niversity of Sydney0 sites200 target enrollmentJuly 7, 2016

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Atrial Fibrillation
Sponsor
niversity of Sydney
Enrollment
200
Status
Not yet recruiting
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 7, 2016
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\) Males and females with a history of paroxysmal (at least 2 prior attacks) or persistent AF (\<12 months duration \[in sinus rhythm at study entry]);
  • 2\) Age 18\-75;
  • 3\) Polysomnography diagnosed OSA of at least moderate severity (AHI \>\=15\);
  • 4\) Ability to provide informed consent.

Exclusion Criteria

  • 1\) Severe OSA related hypoxemia (\>10% sleep time with oxygen saturation \<80%) and/or awake oxygen saturation less than 92%%
  • 2\) Severe respiratory disease (eg Chronic Obstructive Pulmonary Disease or (COPD)
  • 3\) Current or prior mechanical treatment for OSA with CPAP or MAS
  • 4\) \>50% of apnoeas and/or hyponeas associated with Cheyne\-Stokes Respiration (CSR) or Central Sleep Apnoea (CSA)
  • 5\) Increased risk of sleep\-related accident and / or excessive sleepiness defined by any of:
  • \* Severe sleepiness as defined by Epworth Sleepiness Scale (\>15\)
  • \*Driver occupation (eg taxi, courier or truck driver)
  • \*Sleepiness\-related motor vehicle accident, or near accident, within last 12 months prior to enrolment
  • 6\) Any relative or absolute contra\-indication to CPAP or MAS therapy including chronic cranial injury; recurrent pneumothorax; indication for oral\-pharyngeal surgery, edentulous, or loose teeth
  • 7\) Any severe other cardiac disease likely to impact ability to comply:

Outcomes

Primary Outcomes

Not specified

Similar Trials